SNDL Inc. (SNDL)
USD 1.7
(-2.86%)
USD 1.7
(-2.86%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 136.49 Million CAD | -2.24% |
| 2022 | 139.62 Million CAD | 402.81% |
| 2021 | 27.76 Million CAD | 2593.4% |
| 2020 | 1.03 Million CAD | -93.65% |
| 2019 | 16.22 Million CAD | 13849.71% |
| 2018 | 116.32 Thousand CAD | 579.31% |
| 2017 | 17.12 Thousand CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 124.99 Million CAD | 0.0% |
| 2024 Q1 | 128.81 Million CAD | 0.0% |
| 2023 Q4 | 136.49 Million CAD | -0.52% |
| 2023 Q3 | 137.2 Million CAD | 0.78% |
| 2023 Q1 | 142.77 Million CAD | 2.26% |
| 2023 FY | 136.49 Million CAD | -2.24% |
| 2023 Q2 | 136.13 Million CAD | -4.65% |
| 2022 Q3 | 236.91 Million CAD | -1.02% |
| 2022 Q1 | 242.45 Million CAD | 773.11% |
| 2022 FY | 139.62 Million CAD | 402.81% |
| 2022 Q4 | 139.62 Million CAD | -41.07% |
| 2022 Q2 | 239.36 Million CAD | -1.27% |
| 2021 Q1 | 924 Thousand CAD | -10.38% |
| 2021 FY | 27.76 Million CAD | 2593.4% |
| 2021 Q4 | 27.76 Million CAD | 37.44% |
| 2021 Q3 | 20.2 Million CAD | 2413.06% |
| 2021 Q2 | 804 Thousand CAD | -12.99% |
| 2020 Q1 | 16.56 Million CAD | 2.06% |
| 2020 Q4 | 1.03 Million CAD | -97.92% |
| 2020 FY | 1.03 Million CAD | -93.65% |
| 2020 Q3 | 49.54 Million CAD | -63.51% |
| 2020 Q2 | 135.77 Million CAD | 719.87% |
| 2019 Q4 | 16.22 Million CAD | -81.83% |
| 2019 Q3 | 89.32 Million CAD | -49.1% |
| 2019 Q1 | 42.47 Million CAD | 31.39% |
| 2019 Q2 | 175.49 Million CAD | 313.15% |
| 2019 FY | 16.22 Million CAD | 13849.71% |
| 2018 FY | 116.32 Thousand CAD | 579.31% |
| 2018 Q4 | 32.32 Million CAD | 0.0% |
| 2017 FY | 17.12 Thousand CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Theratechnologies Inc. | 51.26 Million USD | -166.269% |
| Harrow Health, Inc. | 183.17 Million USD | 25.484% |
| Dynavax Technologies Corporation | 252.41 Million USD | 45.926% |
| Biofrontera Inc. | 804 Thousand USD | -16876.617% |
| Cronos Group Inc. | 1.55 Million USD | -8655.099% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -156787.356% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 72.609% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | -299.216% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -29898.242% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -967.666% |
| Radius Health, Inc. | 339.66 Million USD | 59.816% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| DURECT Corporation | 2.7 Million USD | -4951.517% |
| ProPhase Labs, Inc. | 10.25 Million USD | -1230.591% |
| Safety Shot Inc | 304.9 Thousand USD | -44665.125% |
| Phibro Animal Health Corporation | 458.28 Million USD | 70.217% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -116431.346% |
| Alvotech | 1.02 Billion USD | 86.72% |
| Assertio Holdings, Inc. | 38.51 Million USD | -254.396% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -311.17% |
| Rockwell Medical, Inc. | 8.29 Million USD | -1545.87% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -25221.547% |
| Procaps Group S.A. | 28.41 Million USD | -380.436% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | -924.253% |
| SCYNEXIS, Inc. | 12.15 Million USD | -1022.559% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -1154.868% |
| Viatris Inc. | 16.18 Billion USD | 99.157% |
| OptiNose, Inc. | 611 Thousand USD | -22239.116% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -40523.707% |
| Tilray Brands, Inc. | 287.93 Million USD | 52.596% |
| PetIQ, Inc. | 437.82 Million USD | 68.825% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -25221.547% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 47.158% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Alimera Sciences, Inc. | 64.48 Million USD | -111.652% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 72.142% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -100938.575% |
| Organogenesis Holdings Inc. | 60.74 Million USD | -124.697% |
| Journey Medical Corporation | 14.62 Million USD | -833.47% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -1890.444% |
| Alpha Teknova, Inc. | 13.25 Million USD | -930.051% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -18857.222% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | -13.262% |
| PainReform Ltd. | 30 Thousand USD | -454873.333% |
| Cosmos Health Inc. | 3.03 Million USD | -4396.76% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | -316.642% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -1989.59% |
| Embecta Corp. | 1.62 Billion USD | 91.603% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 73.435% |
| Incannex Healthcare Limited | 210 Thousand USD | -64896.19% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -606962.8% |
| Shineco, Inc. | 10.01 Million USD | -1262.558% |
| Procaps Group, S.A. | 28.41 Million USD | -380.436% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 55.923% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | -49.866% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 77.847% |
| Alvotech | 1.02 Billion USD | 86.72% |
| Hempacco Co., Inc. | 5.93 Million USD | -2201.332% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | -142.799% |
| Bright Green Corporation | 201.78 Thousand USD | -67542.963% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 72.786% |
| Kamada Ltd. | 7.43 Million USD | -1735.063% |
| Indivior PLC | 235.66 Million USD | 42.083% |
| Evoke Pharma, Inc. | 5 Million USD | -2629.84% |
| Flora Growth Corp. | 942 Thousand USD | -14389.597% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -606962.8% |
| Evolus, Inc. | 120.35 Million USD | -13.404% |
| HUTCHMED (China) Limited | 48.18 Million USD | -183.243% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 76.834% |
| Akanda Corp. | 2.49 Million USD | -5365.9% |